drugset

drugset / Trial / NCT04909931

Vitamin D Supplementation on Outcome and Disease Activity.

NCT04909931 ↗

Completed 60 enrolled Department of Medical Services Ministry of Public Health of Thailand

RandomizedSequentialDouble-blindTreatment

Summary

To study efficacy of Vitamin D on outcome and disease activity ; DAS28-ESR in Rheumatoid arthritis patients at Rajavithi hospital .

Timeline

Start: 2021-05-01
Primary completion: 2022-05-15
Completion: 2022-12-01

Publications

Background Polasik K, Piotrowska E, Lipinska B, Witkowski JM, Bryl E, Tukaj S. Vitamin D status in patients with rheumatoid arthritis: a correlation analysis with disease activity and progression, as well as serum IL-6 levels. Acta Biochim Pol. 2017;64(4):667-670. doi: 10.18388/abp.2017_1636. Epub 2017 Dec 5.
Background Gopal K, Thevarajah M, Ng CM, Raja J. Effects of vitamin D on disease activity and serum interleukin-6 in rheumatoid arthritis. Int J Rheum Dis. 2019 May;22(5):834-841. doi: 10.1111/1756-185X.13484. Epub 2019 Feb 6.
Background Aslam MM, John P, Bhatti A, Jahangir S, Kamboh MI. Vitamin D as a Principal Factor in Mediating Rheumatoid Arthritis-Derived Immune Response. Biomed Res Int. 2019 May 7;2019:3494937. doi: 10.1155/2019/3494937. eCollection 2019.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ergocalciferol	Small molecule	40000 iu	—

Indications

No indication recorded.